Details for 2017754571
Up to date per 01.04.2026
Actions
Details for 2017754571
Deleted
European Patent
19.06.2019 A
06.10.2021 B1
09.08.2016
US
201662372553 P
01.09.2016
US
201662382479 P
02.09.2016
US
201662382977 P
27.09.2016
US
201662400358 P
18.04.2017
US
201762486554 P
C07D 471/16 20060101AFI20210126BHEP
Owner
Teva Pharmaceuticals International GmbHSchlüsselstrasse 12 8645 JonaCH
Representative
No representatives present
Inventor
MITTELMAN, Ariel13/4 Shimon Hatsadik St. EladIL
FUCHS, Ido48 Maskin St. Apt. 21 Petah TikvaIL
SHACHANTOV, SharonaShrat Moshe 21/7 Kfar-SabaIL
RUDIK, Doron9 Levona St. ModiinIL
SELLA-EREZ, Rotem9/6 Sderot Chen St. Tel-AvivIL